Karriereverlauf von Feng Tian
Ehemalige bekannte Positionen von Feng Tian
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.07.2018 | 01.11.2020 |
Vorstandsvorsitzender | 01.07.2018 | 15.08.2022 | |
Vorsitzender | 01.11.2020 | 15.08.2022 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.07.2018 | |
Präsident | 01.07.2018 | 15.08.2022 | |
LuxVitae Therapeutics, Inc. | Gründer | - | - |
AMBRX INC | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Technik-/Wissenschafts-/F&E-Leiter | 17.06.2015 | - | |
Präsident | - | - |
Ausbildung von Feng Tian
University of Florida | Doctorate Degree |
Peking University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Cayman Islands | 2 |
China | 2 |
Operativ
Chief Executive Officer | 2 |
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
LuxVitae Therapeutics, Inc. |